Page last updated: 2024-11-03

propranolol and Chronic Hepatitis C

propranolol has been researched along with Chronic Hepatitis C in 9 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research Excerpts

ExcerptRelevanceReference
"Propranolol bears antioxidant, anti-inflammatory, and antiangiogenic properties and antitumoral effects and therefore is potentially active in the prevention of hepatocellular carcinoma (HCC)."7.78Effect of long-term propranolol treatment on hepatocellular carcinoma incidence in patients with HCV-associated cirrhosis. ( Aout, M; Beaugrand, M; Bourcier, V; Ganne-Carrie, N; Grando-Lemaire, V; Mahmoudi, A; Nkontchou, G; Roulot, D; Trinchet, JC; Vicaut, E, 2012)
"A case of angioedema secondary to propranolol therapy in a patient with chronic hepatitis C virus (HCV) infection is reported."7.76Propranolol-induced angioedema in a patient with chronic hepatitis C virus infection. ( Artacho-Criado, S; Dorantes-Calderon, B; Grande-Santamaria, L; Márquez-Saavedra, E; Morillo-Verdugo, R; Romero-Gómez, M, 2010)
"Sofosbuvir is a direct-acting antiviral drug used to treat chronic hepatitis C infection."3.85Ventricular Extrasystoles after First Dose of Sofosbuvir in a Patient Treated with Propranolol but not with Amiodarone: A Case Report. ( Baghazza, S; Bencherif, R; Chaabna, K; Djezzar, S; Guehimeche, R; Mallem, D; Rouabhia, S; Sadelaoud, M; Sadouki, H, 2017)
"Propranolol bears antioxidant, anti-inflammatory, and antiangiogenic properties and antitumoral effects and therefore is potentially active in the prevention of hepatocellular carcinoma (HCC)."3.78Effect of long-term propranolol treatment on hepatocellular carcinoma incidence in patients with HCV-associated cirrhosis. ( Aout, M; Beaugrand, M; Bourcier, V; Ganne-Carrie, N; Grando-Lemaire, V; Mahmoudi, A; Nkontchou, G; Roulot, D; Trinchet, JC; Vicaut, E, 2012)
" In this issue of the journal (beginning on page 1007), Nkontchou and colleagues report their retrospective observational finding that the β-blocker propranolol was associated with a highly statistically significant reduction in the incidence of hepatocellular carcinoma in patients with advanced cirrhosis and related esophageal varices."3.78Can propranalol prevent hepatocellular carcinoma? ( London, WT; McGlynn, KA, 2012)
"A case of angioedema secondary to propranolol therapy in a patient with chronic hepatitis C virus (HCV) infection is reported."3.76Propranolol-induced angioedema in a patient with chronic hepatitis C virus infection. ( Artacho-Criado, S; Dorantes-Calderon, B; Grande-Santamaria, L; Márquez-Saavedra, E; Morillo-Verdugo, R; Romero-Gómez, M, 2010)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's6 (66.67)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Dai, EH1
Guo, XR1
Wang, JT1
Hu, QG1
Li, JH1
Tang, QY1
Zu, HM1
Huan, H1
Wang, Y1
Gao, YF1
Hu, GQ1
Li, W1
Liu, ZJ1
Ma, QP1
Song, YL1
Yang, JH1
Zhu, Y1
Huang, SD1
Meng, ZJ1
Bai, B1
Chen, YP1
Gao, C1
Huang, MX1
Jin, SQ1
Lu, MZ1
Xu, Z1
Zhang, QH1
Zheng, S1
Zeng, QL1
Qi, XL1
Rouabhia, S1
Baghazza, S1
Sadouki, H1
Djezzar, S1
Bencherif, R1
Guehimeche, R1
Sadelaoud, M1
Mallem, D1
Chaabna, K1
Abd Alla, MD1
Eid, EMM1
Soliman, AIA1
Elhawary, MA1
Kilany, YF1
Abd-Almonaem, G1
Bayoumi, SS1
Moursy, MRA1
Al-Zaem, FAM1
Márquez-Saavedra, E1
Artacho-Criado, S1
Morillo-Verdugo, R1
Grande-Santamaria, L1
Dorantes-Calderon, B1
Romero-Gómez, M1
Kim, BK1
Choi, YS1
Park, YH1
Lee, SU1
Nkontchou, G1
Aout, M1
Mahmoudi, A1
Roulot, D1
Bourcier, V1
Grando-Lemaire, V1
Ganne-Carrie, N1
Trinchet, JC1
Vicaut, E1
Beaugrand, M1
London, WT1
McGlynn, KA1
Yang, WS1
Chu, PL1
Liu, CH1
Chung, GB1
Wu, KD1
Perelló, A1
Escorsell, A1
Bru, C1
Gilabert, R1
Moitinho, E1
García-Pagán, JC1
Bosch, J1

Trials

1 trial available for propranolol and Chronic Hepatitis C

ArticleYear
PORTAL HYPERTENSION TREATMENT WITH CANDESARTAN PLUS PROPRANOLOL FOR NINE MONTHS RESTORES NORMAL PORTAL CIRCULATION HEMODYNAMIC PATTERN.
    Journal of the Egyptian Society of Parasitology, 2016, Volume: 46, Issue:3

    Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Drug Administration Schedule; Drug Ther

2016

Other Studies

8 other studies available for propranolol and Chronic Hepatitis C

ArticleYear
[Investigate of the etiology and prevention status of liver cirrhosis].
    Zhonghua yi xue za zhi, 2023, Mar-28, Volume: 103, Issue:12

    Topics: Carvedilol; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Diseases, Alc

2023
Ventricular Extrasystoles after First Dose of Sofosbuvir in a Patient Treated with Propranolol but not with Amiodarone: A Case Report.
    Reviews on recent clinical trials, 2017, Volume: 12, Issue:3

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antiviral Agents; Dose-Response Relationship, Drug; Echoca

2017
Propranolol-induced angioedema in a patient with chronic hepatitis C virus infection.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, Jul-15, Volume: 67, Issue:14

    Topics: Angioedema; Anti-Arrhythmia Agents; Female; Hepatitis C, Chronic; Humans; Middle Aged; Propranolol;

2010
Interferon-alpha-induced destructive thyroiditis followed by Graves' disease in a patient with chronic hepatitis C: a case report.
    Journal of Korean medical science, 2011, Volume: 26, Issue:12

    Topics: Adult; Antiviral Agents; Female; Graves Disease; Hepatitis C, Chronic; Humans; Interferon-alpha; Met

2011
Effect of long-term propranolol treatment on hepatocellular carcinoma incidence in patients with HCV-associated cirrhosis.
    Cancer prevention research (Philadelphia, Pa.), 2012, Volume: 5, Issue:8

    Topics: Aged; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Human

2012
Can propranalol prevent hepatocellular carcinoma?
    Cancer prevention research (Philadelphia, Pa.), 2012, Volume: 5, Issue:8

    Topics: Carcinoma, Hepatocellular; Female; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; M

2012
Thyrotoxic periodic paralysis induced by pegylated interferon alpha plus ribavirin for chronic hepatitis C.
    Journal of clinical gastroenterology, 2008, Volume: 42, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Antiviral Agents; Carbimazole; Drug Therapy,

2008
Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis.
    Hepatology (Baltimore, Md.), 1999, Volume: 30, Issue:6

    Topics: Adult; Fatty Liver, Alcoholic; Female; Hepatic Veins; Hepatitis C, Chronic; Humans; Liver Cirrhosis;

1999